
Depram25 mg
Square Pharmaceuticals PLC.
Imipramine is a tricyclic antidepressant (TCA) indicated for the following: Depression (established/FDA-approved use): Treatment of symptoms of depression, including endogenous depression, in adults.
Imipramine is a tricyclic antidepressant (TCA) indicated for the following:
Imipramine and other antidepressants carry an FDA boxed warning for increased risk of suicidal thinking and behavior in children, adolescents, and young adults under 25 years of age, particularly during the early weeks of treatment or after dose changes. Close clinical monitoring is required.
| Setting | Initial Dose | Usual/Maximum Dose |
|---|---|---|
| Outpatient | 75 mg/day in divided doses | Up to 150-200 mg/day; may be given as a single bedtime dose once stabilized |
| Hospitalized | 100-150 mg/day | May increase gradually up to 250-300 mg/day if response inadequate after 2 weeks |
Start at a lower dose of 25-50 mg/day; usual maximum around 100 mg/day, adjusted based on tolerability and response.
| Age | Typical Dose (at bedtime) |
|---|---|
| 6-11 years | 25 mg/day, may increase to 50 mg/day if needed after 1 week; not to exceed 2.5 mg/kg/day |
| 12 years and older | 25-75 mg/day at bedtime; not to exceed 2.5 mg/kg/day |
Treatment should be periodically reassessed; not intended as long-term therapy without re-evaluation. Imipramine should be tapered gradually rather than stopped abruptly to avoid discontinuation symptoms.
Use with caution and reduced dosing in patients with hepatic impairment, as Imipramine is extensively hepatically metabolized; specific validated dose adjustments are not well established, so close monitoring is advised.
Common side effects of Imipramine include:
Less common but serious effects include cardiac conduction abnormalities and arrhythmias, seizures, urinary retention, and increased risk of suicidal thinking/behavior in younger patients (see Precautions and Warnings). If severe or persistent side effects occur while taking Imipramine, contact a physician promptly.
Imipramine is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.